IMPA1 is an enzyme responsible for inositol synthesis; deficiency in IMPA1 leads to a decline in inositol and mitochondrial fission, ultimately leading to the development of diabetes and mitochondrial diseases (Hsu et al., 2021). Here, IMPA1 is linked to inborn mitochondrial metabolism disorder.